- Please check and comment entries here.
Sonodynamic therapy is an effective treatment for eliminating tumor cells by irradiating sonosentitizer in a patient’s body with higher penetration ultrasound and inducing the free radicals. Titanium dioxide has attracted the most attention due to its properties among many nanosensitizers. Hence, in this study, carbon doped titanium dioxide, one of inorganic materials, is applied to avoid the foregoing, and furthermore, carbon doped titanium dioxide is used to generate ROS under ultrasound irradiation to eliminate tumor cells. Spherical carbon doped titanium dioxide nanoparticles are synthesized by the sol-gel process. The forming of C-Ti-O bond may also induce defects in lattice which would be beneficial for the phenomenon of sonoluminescence to improve the e ectiveness of sonodynamic therapy. By dint of DCFDA, WST-1, LDH and the Live/Dead test, carbon doped titanium dioxide nanoparticles are shown to be a biocompatible material which may induce ROS radicals to suppress the proliferation of 4T1 breast cancer cells under ultrasound treatment. From in vivo study, carbon doped titanium dioxide nanoparticles activated by ultrasound may inhibit the growth of the 4T1 tumor, and it showed a significant di erence between sonodynamic therapy (SDT) and the other groups on the seventh day of the treatment.
Photodynamic therapy (PDT) is limited due to the shallow penetration depth of light sources into tumor tissue. In previous studies, we used X-ray as an alternative light source which provided a novel therapeutic approach for deep-seated tumor/cancer treatment; however, the annual radiation dose limit was another issue. Thus, an alternative therapy with fewer side effects was proposed by Umemura and Yumita, called ‘‘Sonodynamic therapy (SDT)’’. SDT can focus the ultrasound energy on the deeply located tumor site, which overcomes the shortcoming of PDT. SDT is considered to be a safer and more acceptable therapy for patients compared to radiotherapy and chemotherapy. It is noninvasive, and the apparatus is relatively inexpensive.
SDT consists of three basic elements: ultrasound, sonosensitizer and oxygen molecules. The mechanism of SDT is that the nonthermal effect of acoustic cavitation generated by sonoluminescence, and the sonoluminescent light activates the sonosensitizer, leading to the electronic excitement of the sonosensitizer. When the excited sonosensitizer decays back to the ground state, the released energy transfers to oxygen to generate the highly reactive singlet oxygen (1O2). Meanwhile, the energy may lead to pyrolysis reaction of the water near the exposed site of ultrasound and generate hydroxyl radicals (•OH). These reactive oxygen species (ROS) may cause the death of the tumor cells afterwards. ROS plays an important role in cellular signaling pathways, such as metabolism, growth, differentiation and death signaling, and react with molecules by reversible oxidative modifications. Excess generation of ROS may cause cell senescence and death to intracellular biomacromolecules, such as protein, lipid, RNA and DNA, via oxidative damage.
Ultrasound is a mechanical wave with periodic vibrations in a continuous medium at frequencies greater than 20 kHz. Ultrasound is able to penetrate tissue with less attenuation of energy. Therefore, it can be applied to medical diagnosis and therapeutic use. For a medical diagnosis purpose, the ultrasound is irradiated at a frequency of 2.0 to 28.0 MHz with low-energy irradiation to prevent tissue from damaging. For therapeutic use, the ultrasound is irradiated at a frequency of 0.5 to 3.0 MHz with higher doses of energy to generate the desired biological results. For SDT, low-intensity ultrasound is used to induce the non-thermal and sono-chemical effects to activate sonosensitizer to cause the damage and even the death of tumor cells. The non-thermal effect of ultrasound in SDT is cavitation that involves formation, growth and collapse of cavitation bubbles. Under ultrasound irradiation, the static pressure of the aqueous solution decreases below the vapor pressure, and water may evaporate into gas bubbles. The cavitation bubbles nucleate in the presence of impurities or pre-existing bubbles in solution and oscillate in the phase under irradiation. During the ultrasound irradiation, bubbles grow increasingly larger and stop growing when the static pressure equals the vapor pressure. They may start to break down from its weakest spot when the static pressure exceeds the vapor pressure, and then collapse (known as inertial cavitation) led to a highly concentrated energy release. The released energy leads to the pyrolysis reaction of the water, which generate (•OH) and short light pulses (known as sonoluminescence). Sonoluminescence involves intense ultraviolet-visible light, which can excite sonosensitizer to generate ROS.
Sonosensitizers play a critical role in SDT that can enhance the effect of ultrasound. The development of sonosensitizers had grown swiftly in recent decades due to the known mechanisms of cell apoptosis for SDT. The porphyrin-based sonosensitizers, such as photofrin, hematoporphyrin, 5-ALA (5-aminolevulinic acid) and chlorin-e6, are the most often used sonosensitizers in SDT research. However, porphyrin-based sonosensitizers have phototoxicity on the skin that may affect both tumor cells and normal cells under a certain wavelength of light or energy irradiation in PDT studies, which means that this issue may also take place in SDT. On the other hand, most sonosensitizers were hydrophobic and easy to aggregate in physiological condition, leading to a reduction in their ROS production. Nonetheless, the development of nanoparticles shows a promising potential to solve these problems. Among many nanosensitizers, titanium dioxide (TiO2) has attracted the most attention due to its properties. TiO2 is widely used in many territories based on low toxicity, high stability, high photocatalytic activity and low cost. Compared to porphyrin-based sonosensitizers which are quickly degraded under oxidizing conditions, TiO2 exhibits high stability because it is highly resistant to degradation by ROS. TiO2 exhibits three kinds of crystal structures, namely anatase, rutile and brookite. Anatase and rutile are the most common in the utilization of crystal structures, and brookite is less used in industrial application. Even though anatase (Eg = 3.2 eV) has a wider bandgap than rutile (Eg = 3.0 eV), anatase shows higher photoactivity due to its larger specific surface area that anatase is more suitable to be used as a photocatalyst. In previous studies, the anatase structure of TiO2 has been utilized as a sonocatalyst to generate ROS under ultrasound irradiation. Nonetheless, the wide bandgap of anatase requires a greater energy to trigger. Carbon has previously been doped in the semiconductors to form a new valence band, thus narrowing the bandgap. The addition of carbon may give TiO2 an excess of conducting electrons or holes which is important for lowering the bandgap.
TiO2 is one of most representative material studied in inorganic sonosensitizers. Nonetheless, the low quantum yield of ROS limits the effectiveness of TiO2 as a sonosensitizer by rapid recombination of the free electron and electron hole. The addition of noble metals, such as Pt and Au, have been reported to retard carrier combination. Pt-doped or Au-doped TiO2 has been confirmed to show therapeutic efficacy and suppress the growth of tumors significantly. However, the price of novel metals would increase the cost of material preparation dramatically. Carbon shows highly promising dopant to narrow the bandgap, reaching similar therapeutic efficacy to a novel metal-based system in a more economical way. The comparative table is listed in Table.
Table 1. The sonosensitizers and the matched ultrasound parameters.
The unstableness of the excited state may cause decay back to the ground state, leading to energy release. The released energy may transfer to oxygen to generate the highly reactive singlet oxygen and water to generate hydroxyl radicals (Figure 1). With the increasing concentration of singlet oxygen and hydroxyl radicals, 4T1 cells would be gradually damaged and lead to cell senescence and death due to oxidative damaging effects. Due to the enhanced permeability and retention (EPR) effect, C-doped TiO2 preferentially accumulates in tumor cells eliciting efficient ROS generation and further increasing the effectiveness of the SDT treatment. It was also revealed that the suppression of the tumor is due to the elevated level of ROS which results in both direct tumor cell death and blood vessel stasis. ROS can induce blood stasis via platelet aggregation or vessel constriction by destroying the endothelial layer. Furthermore, SDT may elevate the level of inflammatory-associated cytokine (including TNF-alpha, IL-6, IL-1) production which is known to stimulate the maturation and function of granulocytes and macrophages.
Figure 1. The possible pathway of 4T1 tumor cell damage induced by SDT.
This entry is adapted from 10.3390/antiox9090880
- sonodynamic therapy;carbon doped titanium dioxide;sonosensitizers;ultrasound;cancer treatment;breast cancer treatment
- format change
- Yang, C.-C.; Sun, Y.-J.; Chung, P.-H.; Chen, W.-Y.; Swieszkowski, W.; Tian, W.; Lin, F.-H. Development of Ce-doped TiO2 activated by X-ray irradiation for alternative cancer treatment. Ceram. Int. 2017, 43, 12675–12683.
- Shin-Ichiro Umemura; Nagahiko Yumita; Ryuichiro Nishigaki; Koshiro Umemura; Mechanism of Cell Damage by Ultrasound in Combination with Hematoporphyrin. Japanese Journal of Cancer Research 1990, 81, 962-966, 10.1111/j.1349-7006.1990.tb02674.x.
- Loredana Serpe; Federica Foglietta; Roberto Canaparo; Nanosonotechnology: the next challenge in cancer sonodynamic therapy. Nanotechnology Reviews 2012, 1, 173-182, 10.1515/ntrev-2011-0009.
- Shibaguchi, H.; Tsuru, H.; Kuroki, M.; Kuroki, M. Sonodynamic cancer therapy: A non-invasive and repeatable approach using low-intensity ultrasound with a sonosensitizer. Anticancer Res. 2011, 31, 2425–2430.
- Wood, A.K.; Sehgal, C.M. A review of low-intensity ultrasound for cancer therapy. Ultrasound Med. Biol. 2015, 41, 905–928.
- Ionel Rosenthal; Sonodynamic therapy??a review of the synergistic effects of drugs and ultrasound. Ultrasonics Sonochemistry 2004, 11, 349-363, 10.1016/j.ultsonch.2004.03.004.
- Xiaoqin Qian; Yuanyi Zheng; Yu Chen; Micro/Nanoparticle-Augmented Sonodynamic Therapy (SDT): Breaking the Depth Shallow of Photoactivation. Advanced Materials 2016, 28, 8097-8129, 10.1002/adma.201602012.
- Zhengzhi Zou; Haocai Chang; Haolong Li; Songmao Wang; Induction of reactive oxygen species: an emerging approach for cancer therapy. Apoptosis 2017, 22, 1321-1335, 10.1007/s10495-017-1424-9.
- Krishna Chaitanya Sadanala; Pankaj Kumar Chaturvedi; You Mi Seo; Jeung Mo Kim; Yong Sam Jo; Yang Koo Lee; Woong Shick Ahn; Sono-photodynamic combination therapy: a review on sensitizers.. Anticancer Research 2014, 34, 4657–4664, .
- Loredana Serpe; Francesca Giuntini; Sonodynamic antimicrobial chemotherapy: First steps towards a sound approach for microbe inactivation. Journal of Photochemistry and Photobiology B: Biology 2015, 150, 44-49, 10.1016/j.jphotobiol.2015.05.012.
- Kazuaki Ninomiya; Chiaki Ogino; Shuhei Oshima; Shiro Sonoke; Shun-Ichi Kuroda; Nobuaki Shimizu; Targeted sonodynamic therapy using protein-modified TiO2 nanoparticles. Ultrasonics Sonochemistry 2012, 19, 607-614, 10.1016/j.ultsonch.2011.09.009.
- W. Zhu; Mohammed Alkhazal; M. Cho; Shu Xiao; Microbubble generation by piezotransducer for biological studies. Review of Scientific Instruments 2015, 86, 124901, 10.1063/1.4936555.
- Bhangu, S.K.; Ashokkumar, M. Theory of Sonochemistry. Top. Curr. Chem. 2016, 374, 56.
- McHale, A.P.; Callan, J.F.; Nomikou, N.; Fowley, C.; Callan, B. Sonodynamic therapy: Concept, mechanism and application to cancer treatment. In Advances in Experimental Medicine and Biology; Springer: Cham, Switzerland, 2016; Volume 880, pp. 429–450.
- Sumit Paliwal; Samir Mitragotri; Ultrasound-induced cavitation: applications in drug and gene delivery. Expert Opinion on Drug Delivery 2006, 3, 713-726, 10.1517/17425247.3.6.713.
- Alireza Khataee; Berkant Kayan; Peyman Gholami; Dimitrios Kalderis; Sema Akay; Sonocatalytic degradation of an anthraquinone dye using TiO 2 -biochar nanocomposite. Ultrasonics Sonochemistry 2017, 39, 120-128, 10.1016/j.ultsonch.2017.04.018.
- Guo-Yun Wan; Yang Liu; Bo-Wei Chen; Yuan-Yuan Liu; Yin-Song Wang; Ning Zhang; Recent advances of sonodynamic therapy in cancer treatment. Cancer Biology & Medicine 2016, 13, 325-338, 10.20892/j.issn.2095-3941.2016.0068.
- Hongyan Xu; Xia Zhang; Rubing Han; Peimin Yang; Haifeng Ma; Yan Song; Zhichao Lu; Weidong Yin; Xiangxia Wu; Hui Wang; et al. Nanoparticles in sonodynamic therapy: state of the art review. RSC Advances 2016, 6, 50697-50705, 10.1039/c6ra06862f.
- Tong, H.; Enomoto, N.; Inada, M.; Tanaka, Y.; Hojo, J. Synthesis of mesoporous TiO2 spheres and aggregates by sol–gel method for dye-sensitized solar cells. Mater. Lett. 2015, 141, 259–262.
- Lin, Y.-T.; Weng, C.-H.; Lin, Y.-H.; Shiesh, C.-C.; Chen, F.-Y. Effect of C content and calcination temperature on the photocatalytic activity of C-doped TiO2 catalyst. Sep. Purif. Technol. 2013, 116, 114–123.
- K. Palanivelu; Ji Im; Young-Seak Lee; Carbon Doping of TiO2for Visible Light Photo Catalysis - A review. Carbon Letters 2007, 8, 214-224, 10.5714/cl.2007.8.3.214.
- Elsa Friehs; Yamen AlSalka; Rebecca Jonczyk; Antonina Lavrentieva; André Jochums; Johanna-Gabriela Walter; Frank Stahl; Thomas Scheper; Detlef Bahnemann; Toxicity, phototoxicity and biocidal activity of nanoparticles employed in photocatalysis. Journal of Photochemistry and Photobiology C: Photochemistry Reviews 2016, 29, 1-28, 10.1016/j.jphotochemrev.2016.09.001.
- Liang, S.; Deng, X.; Xu, G.; Xiao, X.; Wang, M.; Guo, X.; Ma, P.A.; Cheng, Z.; Zhang, D.; Lin, J. A Novel Pt–TiO2 Heterostructure with Oxygen-Deficient Layer as Bilaterally Enhanced Sonosensitizer for Synergistic Chemo-Sonodynamic Cancer Therapy. Adv. Funct. Mater. 2020, 30, 1908598.
- Deepagan, V.G.; You, D.G.; Um, W.; Ko, H.; Kwon, S.; Choi, K.Y.; Yi, G.-R.; Lee, J.Y.; Lee, D.S.; Kim, K.; et al. Long-Circulating Au-TiO2 Nanocomposite as a Sonosensitizer for ROS-Mediated Eradication of Cancer. Nano Lett. 2016, 16, 6257–6264.
- Kazuaki Ninomiya; Kyohei Noda; Chiaki Ogino; Shun-Ichi Kuroda; Nobuaki Shimizu; Enhanced OH radical generation by dual-frequency ultrasound with TiO2 nanoparticles: Its application to targeted sonodynamic therapy. Ultrasonics Sonochemistry 2014, 21, 289-294, 10.1016/j.ultsonch.2013.05.005.
- Yoshimi Harada; Koichi Ogawa; Yutaka Irie; Hitomi Endo; Loreto B. Feril; Tetsuji Uemura; Katsuro Tachibana; Ultrasound activation of TiO2 in melanoma tumors. Journal of Controlled Release 2011, 149, 190-195, 10.1016/j.jconrel.2010.10.012.
- Kazuaki Ninomiya; Aya Fukuda; Chiaki Ogino; Nobuaki Shimizu; Targeted sonocatalytic cancer cell injury using avidin-conjugated titanium dioxide nanoparticles. Ultrasonics Sonochemistry 2014, 21, 1624-1628, 10.1016/j.ultsonch.2014.03.010.
- Wang, L.; Mao, J.; Zhang, G.-H.; Tu, M.-J. Nano-cerium-element-doped titanium dioxide induces apoptosis of Bel 7402 human hepatoma cells in the presence of visible light. World J. Gastroenterol. WJG 2007, 13, 4011–4014.
- Li, Y.; Zhou, Q.; Deng, Z.; Pan, M.; Liu, X.; Wu, J.; Yan, F.; Zheng, H. IR-780 Dye as a Sonosensitizer for Sonodynamic Therapy of Breast Tumor. Sci. Rep. 2016, 6, 25968.
- Morteza Hasanzadeh Kafshgari; Wolfgang H. Goldmann; Insights into Theranostic Properties of Titanium Dioxide for Nanomedicine. Nano-Micro Letters 2020, 12, 22, 10.1007/s40820-019-0362-1.
- Cédric Volanti; Geoffrey Gloire; Alain Vanderplasschen; Nathalie Jacobs; Yvette Habraken; Jacques Piette; Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy. Oncogene 2004, 23, 8649-8658, 10.1038/sj.onc.1207871.
- Yufang Shi; Catherine H Liu; Arthur I Roberts; Jyoti Das; Guangwu Xu; Guangwen Ren; Yingyu Zhang; Liying Zhang; Zeng Rong Yuan; Hung Sheng William Tan; et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know. Cell Research 2006, 16, 126-133, 10.1038/sj.cr.7310017.